TSS
MBRX icon

Two Sigma Securities’s Moleculin Biotech MBRX Stock Holding History

Two Sigma Securities’s Portfolio MBRX Stock Details MBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-35
Closed -$7.59K – 3261
2023
Q2 		$7.59K Sell
35
-1
-3% -$264 ﹤0.01% 2629
2023
Q1 		$13K Buy
+36
New +$15.8K ﹤0.01% 2423
2022
Q1 		– Sell
-59
Closed -$41K – 2349
2021
Q4 		$41K Buy
+59
New +$52.3K ﹤0.01% 1307
2021
Q2 		– Sell
-73
Closed -$111K – 1625
2021
Q1 		$111K Buy
+73
New +$134K 0.01% 689
2020
Q2 		– Sell
-40
Closed -$55K – 1573
2020
Q1 		$55K Buy
40
+34
+567% +$57.9K ﹤0.01% 1182
2019
Q4 		$13K Buy
+6
New +$14K ﹤0.01% 2271
2019
Q1 		– Sell
-9
Closed -$21K – 2202
2018
Q4 		$21K Buy
+9
New +$25.8K ﹤0.01% 1974
2018
Q3 		– Sell
-6
Closed -$24K – 2842
2018
Q2 		$24K Buy
+6
New +$24.6K ﹤0.01% 2554
2018
Q1 		– Sell
-5
Closed -$21K – 2839
2017
Q4 		$21K Buy
+5
New +$21.6K ﹤0.01% 1625
2017
Q3 		– Sell
-34
Closed -$144K – 1100
2017
Q2 		$144K Buy
34
+23
+209% +$50.1K 0.03% 613
2017
Q1 		$28K Buy
+11
New +$38.5K 0.01% 832

Other funds holding MBRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PJSIMP
P.J. Schmidt Investment Management (PJS) Cedarburg, Wisconsin $643M AUM 21.84% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return

Two Sigma Securities's MBRX Position: Q3 2023 in Review

Two Sigma Securities sold out of Moleculin Biotech (MBRX) in Q3 2023, closing a stake of 35 shares — an estimated $7.59K sold.

Two Sigma Securities first reported a position in MBRX in Q1 2017 and held it in 11 quarters. The position peaked at $144K in Q2 2017. 19 funds tracked by Wall St. Rank hold MBRX as of Q3 2023.

  • Two Sigma Securities reported no remaining Moleculin Biotech position as of Q3 2023 after selling out during the quarter.
  • Two Sigma Securities sold 35 Moleculin Biotech shares in Q3 2023, an estimated $7.59K.
  • Two Sigma Securities first reported a position in Moleculin Biotech in Q1 2017 and held it in 11 quarters.
  • Two Sigma Securities's Moleculin Biotech position peaked at $144K in Q2 2017.
  • 19 funds tracked by Wall St. Rank held Moleculin Biotech as of Q3 2023.

Based on Two Sigma Securities's 13F filing for Q3 2023, filed 14 Nov 2023.